These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2750437)

  • 1. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 4. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology.
    Arbyn M; Herbert A; Schenck U; Nieminen P; Jordan J; Mcgoogan E; Patnick J; Bergeron C; Baldauf JJ; Klinkhamer P; Bulten J; Martin-Hirsch P
    Cytopathology; 2007 Jun; 18(3):133-9. PubMed ID: 17573762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 7. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cytology quality assurance in Washington State.
    Taylor V; Frost F
    Acta Cytol; 1992; 36(2):246-50. PubMed ID: 1543009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory closure of cervical cytology laboratories: recommendations for a public health response.
    MMWR Recomm Rep; 1997 Dec; 46(RR-17):1-19. PubMed ID: 9409538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 14. In-house quality assurance program in a state cytology laboratory.
    Gardner NM
    Acta Cytol; 1989; 33(4):487-8. PubMed ID: 2750439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell preparation methods and criteria for sample adequacy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    McGoogan E; Colgan TJ; Ramzy I; Cochand-Priollet B; Davey DD; Grohs HK; Gurley AM; Husain OA; Hutchinson ML; Knesel EA; Linder J; Mango LJ; Mitchell H; Peebles A; Reith A; Robinowitz M; Sauer T; Shida S; Solomon D; Topalidis T; Wilbur DC; Yamauchi K
    Acta Cytol; 1998; 42(1):25-32. PubMed ID: 9479321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in Canadian Native women. Adequacy of the Papanicolaou smear.
    Hislop TG; Band PR; Deschamps M; Clarke HF; Smith JM; Ng VT
    Acta Cytol; 1994; 38(1):29-32. PubMed ID: 8291352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection.
    Davey DD; Cox JT; Austin RM; Birdsong G; Colgan TJ; Howell LP; Husain M; Darragh TM
    J Low Genit Tract Dis; 2008 Apr; 12(2):71-81. PubMed ID: 18369299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.